ID   TRI55_RAT               Reviewed;         545 AA.
AC   Q5PQN5;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 1.
DT   24-JUL-2024, entry version 126.
DE   RecName: Full=Tripartite motif-containing protein 55;
DE            EC=2.3.2.27 {ECO:0000250|UniProtKB:Q9BYV6};
DE   AltName: Full=Muscle-specific RING finger protein 2;
DE            Short=MuRF-2;
DE            Short=MuRF2;
DE   AltName: Full=RING finger protein 29;
GN   Name=Trim55; Synonyms=Murf2, Rnf29;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Heart muscle, and Skeletal muscle;
RX   PubMed=12414993; DOI=10.1242/jcs.00131;
RA   Pizon V., Iakovenko A., van der Ven P.F.M., Kelly R., Fatu C., Fuerst D.O.,
RA   Karsenti E., Gautel M.;
RT   "Transient association of titin and myosin with microtubules in nascent
RT   myofibrils directed by the MURF2 RING-finger protein.";
RL   J. Cell Sci. 115:4469-4482(2002).
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15199100; DOI=10.1242/jcs.01158;
RA   McElhinny A.S., Perry C.N., Witt C.C., Labeit S., Gregorio C.C.;
RT   "Muscle-specific RING finger-2 (MURF-2) is important for microtubule,
RT   intermediate filament and sarcomeric M-line maintenance in striated muscle
RT   development.";
RL   J. Cell Sci. 117:3175-3188(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15802564; DOI=10.1126/science.1110463;
RA   Lange S., Xiang F., Yakovenko A., Vihola A., Hackman P., Rostkova E.,
RA   Kristensen J., Brandmeier B., Franzen G., Hedberg B., Gunnarsson L.G.,
RA   Hughes S.M., Marchand S., Sejersen T., Richard I., Edstroem L., Ehler E.,
RA   Udd B., Gautel M.;
RT   "The kinase domain of titin controls muscle gene expression and protein
RT   turnover.";
RL   Science 308:1599-1603(2005).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: E3 ubiquitin ligase that plays an important role in
CC       regulating cardiac development and contractility, muscle growth,
CC       metabolism, and fiber-type differentiation. Acts as a critical factor
CC       that regulates cardiomyocyte size during development in concert with
CC       TRIM63 by regulating E2F1-mediated gene expression. Plays a role in
CC       apoptosis induction in cardiomyocytes by promoting ubiquitination of
CC       the DUSP1 phosphatase. Promotes non-canonical NF-kappa-B signaling and
CC       B-cell-mediated immune responses by mediating NFKB2 'Lys-48'-linked
CC       ubiquitination and processing. In turn, NFKB2 is further processed by
CC       valosin-containing protein/VCP, an ATPase that mediates ubiquitin-
CC       dependent protein degradation by the proteasome. May play a role in
CC       preventing macrophages from producing inflammatory factors and
CC       migrating by downregulating the level of nuclear NF-kappa-B subunit
CC       RELA. Modifies also PPARG via polyubiquitination and accelerates PPARG
CC       proteasomal degradation to inhibit its activity.
CC       {ECO:0000250|UniProtKB:G3X8Y1, ECO:0000250|UniProtKB:Q9BYV6}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000250|UniProtKB:Q9BYV6};
CC   -!- SUBUNIT: Homooligomer and heterooligomer (Probable). Interacts with
CC       titin/TTN. Interacts with myosins. Interacts with SQSTM1 and NBR1.
CC       Probably interacts with TRIM63 and TRIM54 (By similarity).
CC       {ECO:0000250, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:G3X8Y1}. Cytoplasm
CC       {ECO:0000250|UniProtKB:G3X8Y1}. Note=TLR4 signaling pathway promotes
CC       nuclear translocation. {ECO:0000250|UniProtKB:G3X8Y1}.
CC   -!- PTM: Targeted for degradation through the proteasomal and lysosomal
CC       pathways in the presence of SUMO3. {ECO:0000250|UniProtKB:Q9BYV6}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC087100; AAH87100.1; -; mRNA.
DR   RefSeq; NP_001012218.1; NM_001012218.1.
DR   AlphaFoldDB; Q5PQN5; -.
DR   SMR; Q5PQN5; -.
DR   BioGRID; 265529; 1.
DR   CORUM; Q5PQN5; -.
DR   IntAct; Q5PQN5; 2.
DR   STRING; 10116.ENSRNOP00000017125; -.
DR   PhosphoSitePlus; Q5PQN5; -.
DR   PaxDb; 10116-ENSRNOP00000017125; -.
DR   Ensembl; ENSRNOT00065033105; ENSRNOP00065026470; ENSRNOG00065019641.
DR   GeneID; 365751; -.
DR   KEGG; rno:365751; -.
DR   UCSC; RGD:1306943; rat.
DR   AGR; RGD:1306943; -.
DR   CTD; 84675; -.
DR   RGD; 1306943; Trim55.
DR   VEuPathDB; HostDB:ENSRNOG00000012723; -.
DR   eggNOG; KOG2177; Eukaryota.
DR   HOGENOM; CLU_013137_5_3_1; -.
DR   InParanoid; Q5PQN5; -.
DR   OrthoDB; 5383069at2759; -.
DR   PhylomeDB; Q5PQN5; -.
DR   TreeFam; TF331669; -.
DR   PRO; PR:Q5PQN5; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000012723; Expressed in heart and 9 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISO:RGD.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0050904; P:diapedesis; ISO:RGD.
DR   GO; GO:0002523; P:leukocyte migration involved in inflammatory response; ISO:RGD.
DR   GO; GO:1905517; P:macrophage migration; ISO:RGD.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; ISO:RGD.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   CDD; cd19832; Bbox2_MuRF2_C-II; 1.
DR   CDD; cd16760; RING-HC_MuRF2; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR017903; COS_domain.
DR   InterPro; IPR050143; TRIM/RBCC.
DR   InterPro; IPR027370; Znf-RING_euk.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR24103; E3 UBIQUITIN-PROTEIN LIGASE TRIM; 1.
DR   PANTHER; PTHR24103:SF640; TRIPARTITE MOTIF-CONTAINING PROTEIN 55; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   SMART; SM00336; BBOX; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57845; B-box zinc-binding domain; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS51262; COS; 1.
DR   PROSITE; PS50119; ZF_BBOX; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Cytoplasm; Metal-binding; Muscle protein; Nucleus;
KW   Reference proteome; Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..545
FT                   /note="Tripartite motif-containing protein 55"
FT                   /id="PRO_0000056287"
FT   DOMAIN          269..327
FT                   /note="COS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00586"
FT   ZN_FING         26..82
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         119..161
FT                   /note="B box-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   REGION          324..378
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          406..528
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          219..258
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        327..353
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        411..430
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        468..482
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        491..518
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         124
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         127
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         147
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         153
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
SQ   SEQUENCE   545 AA;  59980 MW;  2B884C66708CCB36 CRC64;
     MSTSLNYKSF SKEQQTMDNL EKQLICPICL EMFTKPVVIL PCQHNLCRKC ASDIFQASNP
     YLPTRGGTTV ASGGRFRCPS CRHEVVLDRH GVYGLQRNLL VENIIDIYKQ ESTRPEKKLD
     QPMCEEHEEE RINIYCLNCE VPTCSLCKVF GAHKDCQVAP LTHVFQRQKS ELSDGIAVLV
     GSNDRVQGVI SQLEDTCKTI EECCRKQKQD LCEKFDHLYS ILEERKTEMT QAITRTQEEK
     LEHVRTLIRK YSDHLENVSK LVESGIQFMD EPEMAVFLQN AKTLLQKITE ASKAFQMEKI
     EQGYEIMNNF TVNLNREEKI IREIDFSREE EDEDDEGEVD EEGEGEDAVE VEEAENVQVA
     SSGEEETLEK AAEPSELAAE IQAASGPLLA SSPDSVSSLP PAADVLVTQG EVVPTDSQQT
     TQSETSGPSA AETADPLFYP SWYKGQSRKM ISNPPHTPGG EGLSQIGPSA AEDSSVQSAE
     VAEAAANEQA AVSGKESSST AATSQIGFEA SSPQGQAAAL GSGGGADSEP ARHVFSFSWL
     NSLNE
//
